Evidence map›Paper›PMID 21182223›Full record

ReviewWorld journal of gastroenterology2010

Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Alexander M Mathes

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Antifibrogenic effect of melatonin in rats with experimental liver cirrhosis induced by carbon tetrachloride.JGH open : an open access journal of gastroenterology and hepatology · 2018
    Article
  10. Melatonin and Hippo Pathway: Is There Existing Cross-Talk?International journal of molecular sciences · 2017
    Article
  11. Melatonin Alleviates Liver Apoptosis in Bile Duct Ligation Young Rats.International journal of molecular sciences · 2016
    Article
  12. Article
  13. Impact of melatonin receptor deletion on intracellular signaling in spleen cells of mice after polymicrobial sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alexander M MathesDepartment of Anesthesiology, Critical Care and Pain Medicine, Saarland University Hospital, Kirrberger Straße, D-66421 Homburg (Saar), Germany. alexander.mathes@uks.eu
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin, the hormone of darkness and messenger of the photoperiod, is also well known to exhibit strong direct and indirect antioxidant properties. Melatonin has previously been demonstrated to be a powerful organ protective substance in numerous models of injury; these beneficial effects have been attributed to the hormone's intense radical scavenging capacity. The present report reviews the hepatoprotective potential of the pineal hormone in various models of oxidative stress in vivo, and summarizes the extensive literature showing that melatonin may be a suitable experimental substance to reduce liver damage after sepsis, hemorrhagic shock, ischemia/reperfusion, and in numerous models of toxic liver injury. Melatonin's influence on hepatic antioxidant enzymes and other potentially relevant pathways, such as nitric oxide signaling, hepatic cytokine and heat shock protein expression, are evaluated. Based on recent literature demonstrating the functional relevance of melatonin receptor activation for hepatic organ protection, this article finally suggests that melatonin receptors could mediate the hepatoprotective actions of melatonin therapy.

Indexed as

AnimalsAntioxidantsCytokinesDisease Models, AnimalHumansLiverMelatoninOxidative StressReceptors, MelatoninShock, HemorrhagicSignal TransductionAntioxidantsCytokinesMelatoninReceptors, Melatonin

Identifiers

PMID21182223
PMCPMC3012585
OpenAlexW2136992112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.